Notícias

Potash sales hit records as automation gains offset phosphate margin pressure.

Nutrien Ltd. recently reported second-quarter 2026 results, with sales of US$10,812 million and net income of US$1,214 million, and declared a US$0.55 per-share quarterly dividend payable on October 16, 2026, to shareholders of record on September 29, 2026. The company also completed a US$261 million buyback of 3,732,920 shares and raised its 2026 potash sales volume guidance, underscoring management’s focus on returning capital while leaning into areas of strongest demand. Now we’ll examine...

NTR's Q2 sales topped estimates as potash gains and stronger benchmark prices helped offset lower volumes and higher sulfur costs.

Nutrien (NYSE:NTR) reported second-quarter adjusted EBITDA of $2.4 billion and first-half adjusted EBITDA of $3.5 billion, up 6% from a year earlier, as record potash sales volumes, proprietary-product margin growth and operating execution supported results. Cash provided by operating activities in

Moby summary of Nutrien Ltd.'s Q2 2026 earnings call

Nutrien (NTR) delivered earnings and revenue surprises of -3.33% and +1.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Intrepid Potash (IPI) delivered earnings and revenue surprises of +47.37% and +0.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Nutrien (NTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Kenneth Seitz: Good morning, and thank you for joining us today to review our first quarter results and the outlook for our business. The ongoing Middle East conflict has disrupted global fertilizer and energy markets, resulting in higher global benchmark prices and input costs. Despite heightened geopolitical uncertainty, Nutrien's strategic priorities, capital allocation approach and full year guidance remain unchanged.

Nutrien (TSX:NTR) is reviewing major assets, including its Trinidad nitrogen facility, phosphate operations, and Brazilian retail arm. The company is considering options such as asset sales or restructurings as part of a broader portfolio review. The internal process is ongoing and could reshape Nutrien's business mix and operational footprint. Nutrien, a large player in crop inputs and agricultural retail, is reassessing key parts of its business at a time when fertilizer markets and...

Nutrien (NYSE:NTR) reported higher first-quarter adjusted EBITDA and record potash sales volumes, while management said its full-year guidance remains unchanged despite disruptions to global fertilizer and energy markets tied to the ongoing Middle East conflict. President and CEO Ken Seitz said the

NTR beat Q1 earnings estimates as record potash volumes, stronger pricing and Retail demand lifted earnings and sales sharply year over year.

Nutrien (NTR) delivered earnings and revenue surprises of +6.99% and +12.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

CF stock heads into Q1 earnings with rising estimates, strong nitrogen demand and pricing tailwinds.

LIN's bottom line beat Q1 estimates as pricing and project start-ups drive growth, with revenues up 8% and EPS rising 10% year over year.

Nutrien heads into Q1 earnings with strong fertilizer demand, rising prices and cost cuts expected to boost results.

Nutrien (NTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.